Amplify Weight Loss Drug & Treatment
$25.90
11
+$0.52+2.07%Friday 19:40
+$0.05+0.2%Friday 22:30After hours
Statistics
Day High
25.95
Day Low
25.95
52W High
27.94
52W Low
23.16
Volume
265
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
1.6%
Dividend
0.41
Upcoming
Expense Ratio
0.59%
0%
1%+
The annual fee that you pay to the fund company for managing your investment. The lower the expense ratio, the better. This is not an investment recommendation.
Dividends
1.6%Dividend Yield
Dec 2025
$0.41
Dec 2024
$0.22
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
87.89%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow THNR. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Holdings
Regions
Sectors
About
The Amplify Weight Loss Drug & Treatment ETF (THNR) offers investors a way to access international firms poised to benefit financially from advancements in weight management pharmaceuticals. Its primary objective is to mirror the investment performance (before any fees or expenses) of the VettaFi Weight Loss Drug & Treatment Index.
Show More
CEO
Country
United States
ISIN
US0321085328
Listings
0 Comments
Share your thoughts
FAQs
What is Amplify Weight Loss Drug & Treatment stock price today?▼
The current price of THNR is $25.90 USD — it has increased by +2.07% in the past 24 hours. Watch Amplify Weight Loss Drug & Treatment stock price performance more closely on the chart.
What is Amplify Weight Loss Drug & Treatment stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on ARCX exchange Amplify Weight Loss Drug & Treatment stocks are traded under the ticker THNR.
Is Amplify Weight Loss Drug & Treatment stock price growing?▼
THNR stock has risen by +4.89% compared to the previous week, the month change is a +5.46% rise, over the last year Amplify Weight Loss Drug & Treatment has showed a +11.14% increase.
Does Amplify Weight Loss Drug & Treatment pay dividends?▼
Yes, THNR dividends are paid annual. The last dividend per share was 0.41 . As of today, Dividend Yield (FWD)% is 1.6%.
In which sector is Amplify Weight Loss Drug & Treatment located?▼
Amplify Weight Loss Drug & Treatment operates in the Finance & Payments sector.
When did Amplify Weight Loss Drug & Treatment complete a stock split?▼
Amplify Weight Loss Drug & Treatment has not had any recent stock splits.
Where is Amplify Weight Loss Drug & Treatment headquartered?▼
Amplify Weight Loss Drug & Treatment is headquartered in Lisle, United States.